Science & Tech
Products
Blog
Join Us
News
Contact
Back
Overview
Product Development
COVID Brain Fog
2023 ADHD in Workplace Report
Publications
Back
Careers at Akili
Akili Ambassador Program
Science & Tech
Overview
Product Development
COVID Brain Fog
2023 ADHD in Workplace Report
Publications
Products
Blog
Join Us
Careers at Akili
Akili Ambassador Program
News
Contact
The Console
Learn more about cognition, digital medicine and our work.
Featured
Outgoing CEO Eddie Martucci's Employee Letter Announcing Leadership Transition and Excitement for the Future
Introducing Focus Score™ with EndeavorOTC™ for adults with ADHD
Could a medical “digital twin” help your child with ADHD?
Business update sent to employees from Akili CEO Eddie Martucci
Advancing the field of cognitive science: using cognitive models to help us better understand patients
In their own words – meet Gage, Gretchen, and Peter
Dr. Scott Kollins: Tackling the Challenges of ADHD Care Management Inertia
In their own words – meet Laurence & Kate
Q&A with Matt Omernick: Reimagining the Patient Experience with Akili on Roblox
Akili’s Vision for Equitable Benefit in Digital Therapeutics
Akili is now listed on Nasdaq [AKLI]
Exploring Video Games as Medicine at SIGGRAPH Asia 2021
Covid-19 is bringing digital therapeutics to the forefront of medicine
EndeavorRx®: Data Snapshot
Ask the Experts: The impact of COVID brain fog on COVID-19 survivors
In their own words – meet Adam & Ash
Q&A with Global Gaming Citizen Dr. Adam Gazzaley
Get the Facts on COVID Brain Fog
In their own words – meet Emily & Brittany
EndeavorRx®: 7 Years of Research
In their own words – meet Kate, Kara and Trey
// Modifying the title text in on the homepage